Results 221 to 230 of about 880,908 (352)
High tumor CD161 expression predicts a survival advantage and marks a Th1-skewed microenvironment. [PDF]
Burns BA+3 more
europepmc +1 more source
This study reports an innovative strategy to improve the safety of OMVs by shielding them with a sophisticated shell composed of DaFe shell and Au nanoparticles, which not only reduces the toxicity of OMVs during circulation but also enables rapid release of these therapeutically active components in tumor for combined therapy involving glucose ...
Fan Zhang+11 more
wiley +1 more source
Expression of the TIGIT axis and the CD39/CD73 purinergic pathway in bone metastasis-derived immune cells. [PDF]
Brauneck E+15 more
europepmc +1 more source
The gut microbiome is a potential target for treating cardiovascular disease. It is found that prophylactic administration of Flavonifractor plautii or its metabolite desaminotyrosine (DAT) exerts pleiotropic cardioprotective effects via promoting cardiomyocyte survival and attenuating cardiac inflammation against myocardial ischemia/reperfusion (I/R ...
Heng Du+21 more
wiley +1 more source
Expanding role of antibodies in kidney transplantation. [PDF]
Abbas K, Mubarak M.
europepmc +1 more source
This study introduces KK2DP7, a dendrimer‐structured peptide adjuvant, as a tool to decode trained immunity's role in antitumor therapy. Splenic CD11b+ cells mediate tumor suppression via TLR2‐IRF7 activation and epigenetic reprogramming, validated by adoptive transfer experiments.
Rui Zhang+5 more
wiley +1 more source
Spatially precise chemo-radio-immunotherapy by antibody drug conjugate directed tumor radiosensitization to potentiate immunotherapies. [PDF]
Mortaja M+4 more
europepmc +1 more source
Clinical immunologic responsiveness in malignant disease.I. Delayed hypersensitivity reaction and the effect of cytotoxic drugs [PDF]
Muhyi Al‐Sarraf+3 more
openalex +1 more source